Cleidion brevipetiolatum
Cleidion brevipetiolatum · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Cleidion brevipetiolatum is a botanical species of significant interest due to its diverse phytochemical profile. Research has highlighted the presence of bioactive ellagitannins within its leaves, which may contribute to various therapeutic properties. Studies specifically focus on the potential medicinal applications of an aqueous-EtOH extract derived from these plant parts. This preparation is being investigated for its ability to influence physiological processes related to inflammatory disorders. Ultimately, the plant shows promise as a natural resource in the management of conditions such as rheumatoid arthritis.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Euphorbiaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Common Names
Cleidion brevipetiolatum is a unique botanical species recognized by its distinct physical characteristics. In many local regions, this plant is widely known by its common name, 棒柄花. This nomenclature provides a helpful linguistic link for enthusiasts looking to identify the specimen in the wild. Understanding these common names is essential for researchers studying the plant's specific ecological niche. Such connections between scientific and traditional naming help bridge the gap between academic study and local knowledge.
Sources: Catalogue of Life (COL)
Taxonomy
Cleidion brevipetiolatum is a distinctive species belonging to the vast kingdom Plantae. Within this biological kingdom, it is specifically classified under the class Equisetopsida. The plant is a member of the diverse order Malpighiales, showcasing its evolutionary connections. It further falls under the family Euphorbiaceae, a group known for its unique botanical characteristics. Finally, this species is identified by its placement within the genus Cleidion.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malpighiales |
| Family | Euphorbiaceae |
| Genus | Cleidion |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Cleidion brevipetiolatum exhibits a diverse geographical range that spans across various regions of Asia. Within the temperate zones of China, this species can be found throughout the South-Central and Southeast provinces, as well as on the island of Hainan. Its presence also extends into the tropical landscapes of Indo-China. Specifically, the plant is documented growing in the lush environments of Laos and Myanmar. This wide distribution highlights the adaptable nature of the species across different Asian climates.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Cleidion brevipetiolatum is a distinctive species characterized by its robust tree growth form. As a self-supporting plant, it maintains its structure independently within its natural habitat. The height of this tree can vary significantly, typically reaching a minimum of 5 meters. In many instances, the species establishes a more substantial presence with a minimum height of 8.5 meters. Ultimately, these impressive specimens can reach a maximum height of 12 meters.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Cleidion brevipetiolatum contains bioactive compounds that show significant promise in treating rheumatoid arthritis. Research indicates that specific ellagitannins isolated from this plant exert therapeutic effects in models of collagen-induced arthritis (CIA). Furthermore, the plant's components effectively treat carrageenan-induced rat paw edema through potent anti-inflammatory actions. These medicinal properties are driven by the ability of its compounds to suppress inflammatory markers and NF-κB activity. Consequently, the plant serves as a valuable source for developing new treatments for various inflammatory conditions.
Preparations
Cleidion brevipetiolatum is prepared as an aqueous-EtOH extract to facilitate the isolation of specific chemical constituents. This particular extraction method was utilized on both the twigs and the leaves of the plant. Through this process, researchers successfully identified several undescribed clerodane diterpenoids and ellagitannins. These isolated compounds, such as cleibreciums A-D and various bractin derivatives, were obtained directly from the aqueous-EtOH preparation. Consequently, the use of this specific solvent mixture proved essential for extracting the bioactive substances found within the species.
Parts used
Cleidion brevipetiolatum serves as a significant source of diverse secondary metabolites, including diterpenoids and tannins. Recent chemical investigations focused on extracting these compounds from the plant's twigs and leaves. Specifically, researchers successfully isolated four new clerodane diterpenoids and two unique ellagitannins from the leaf material. Through extensive spectroscopic and X-ray crystallographic analysis, the precise structures of these bioactive molecules were determined. Preliminary anti-inflammatory assays suggest that certain isolated compounds may even possess the ability to inhibit nitric oxide production in cellular models.